DLK1
Basic information
Region (hg38): 14:100725705-100738224
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DLK1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | |||||
missense | 26 | 36 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 27 | 14 | 11 |
Variants in DLK1
This is a list of pathogenic ClinVar variants found in the DLK1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-100727093-C-G | Inborn genetic diseases | Uncertain significance (Oct 20, 2023) | ||
14-100727130-C-T | Inborn genetic diseases | Uncertain significance (Dec 05, 2022) | ||
14-100727133-A-G | Inborn genetic diseases | Uncertain significance (Dec 17, 2021) | ||
14-100727213-C-T | Central precocious puberty | Uncertain significance (Jun 21, 2023) | ||
14-100728427-A-G | DLK1-related disorder | Benign/Likely benign (Feb 01, 2023) | ||
14-100728431-G-C | Silver-Russell syndrome 1 | Uncertain significance (Apr 15, 2021) | ||
14-100728440-G-T | Uncertain significance (May 01, 2022) | |||
14-100728445-T-A | Inborn genetic diseases | Uncertain significance (Jan 31, 2023) | ||
14-100728975-C-T | DLK1-related disorder | Likely benign (Apr 16, 2019) | ||
14-100728976-G-A | Inborn genetic diseases | Likely benign (Nov 15, 2021) | ||
14-100728998-A-G | Silver-Russell syndrome 1 | Benign (Apr 01, 2023) | ||
14-100729010-G-A | Inborn genetic diseases | Likely benign (Aug 08, 2022) | ||
14-100729017-C-T | DLK1-related disorder | Likely benign (Jul 01, 2023) | ||
14-100729021-C-A | Inborn genetic diseases | Uncertain significance (Dec 08, 2023) | ||
14-100729022-A-T | Benign (Dec 31, 2019) | |||
14-100729029-T-G | Inborn genetic diseases | Uncertain significance (May 22, 2023) | ||
14-100729036-G-A | Inborn genetic diseases | Uncertain significance (Dec 20, 2023) | ||
14-100729048-G-C | Inborn genetic diseases | Uncertain significance (Oct 13, 2023) | ||
14-100729052-A-G | Inborn genetic diseases | Uncertain significance (Apr 12, 2023) | ||
14-100729070-G-A | DLK1-related disorder | Likely benign (Nov 28, 2023) | ||
14-100729185-C-T | Likely benign (Aug 01, 2024) | |||
14-100732047-C-T | Inborn genetic diseases | Uncertain significance (Jul 19, 2023) | ||
14-100732060-C-T | Inborn genetic diseases | Uncertain significance (May 28, 2023) | ||
14-100732089-G-A | DLK1-related disorder | Benign (Dec 31, 2019) | ||
14-100732094-C-A | Inborn genetic diseases | Uncertain significance (Feb 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DLK1 | protein_coding | protein_coding | ENST00000341267 | 5 | 9498 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0346 | 0.958 | 125740 | 0 | 8 | 125748 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.583 | 231 | 257 | 0.898 | 0.0000168 | 2504 |
Missense in Polyphen | 90 | 109.78 | 0.81979 | 1032 | ||
Synonymous | 0.358 | 116 | 121 | 0.959 | 0.00000935 | 769 |
Loss of Function | 2.35 | 5 | 14.7 | 0.340 | 6.30e-7 | 163 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.0000531 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May have a role in neuroendocrine differentiation.;
- Pathway
- Adipogenesis;Canonical and Non-canonical Notch signaling;EMT transition in Colorectal Cancer;Signal Transduction;Signaling by NOTCH1;Signaling by NOTCH;Notch signaling pathway;FOXA2 and FOXA3 transcription factor networks;Activated NOTCH1 Transmits Signal to the Nucleus
(Consensus)
Recessive Scores
- pRec
- 0.356
Intolerance Scores
- loftool
- 0.122
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.6
Haploinsufficiency Scores
- pHI
- 0.891
- hipred
- Y
- hipred_score
- 0.812
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.742
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dlk1
- Phenotype
- immune system phenotype; skeleton phenotype; vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; embryo phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- cell differentiation;negative regulation of Notch signaling pathway
- Cellular component
- extracellular space;cytoplasm;integral component of membrane
- Molecular function
- molecular_function;calcium ion binding